The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Gastrointestinal Neoplasms

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Gastrointestinal Neoplasms


High impact information on Gastrointestinal Neoplasms


Chemical compound and disease context of Gastrointestinal Neoplasms


Biological context of Gastrointestinal Neoplasms


Anatomical context of Gastrointestinal Neoplasms


Gene context of Gastrointestinal Neoplasms


Analytical, diagnostic and therapeutic context of Gastrointestinal Neoplasms


  1. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. Rutqvist, L.E., Johansson, H., Signomklao, T., Johansson, U., Fornander, T., Wilking, N. J. Natl. Cancer Inst. (1995) [Pubmed]
  2. Detection of decay-accelerating factor in stool specimens of patients with colorectal cancer. Mizuno, M., Nakagawa, M., Uesu, T., Inoue, H., Inaba, T., Ueki, T., Nasu, J., Okada, H., Fujita, T., Tsuji, T. Gastroenterology (1995) [Pubmed]
  3. CD44: structure, function, and association with the malignant process. Naor, D., Sionov, R.V., Ish-Shalom, D. Adv. Cancer Res. (1997) [Pubmed]
  4. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C., Taketo, M. Proc. Natl. Acad. Sci. U.S.A. (1995) [Pubmed]
  5. 5-Fluorouracil for gastrointestinal cancer. Ansfield, F.J., Greenspan, E.M. N. Engl. J. Med. (1979) [Pubmed]
  6. Role of fluoropyrimidine Schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinoma. Cao, S., Frank, C., Rustum, Y.M. J. Natl. Cancer Inst. (1996) [Pubmed]
  7. Rheumatoid arthritis, aspirin, and gastrointestinal cancer. Heath, C.W. J. Natl. Cancer Inst. (1993) [Pubmed]
  8. Loss of Lewis antigen expression on erythrocytes in some cancer patients with high serum CA19-9 levels. Hirano, K., Kawa, S., Oguchi, H., Kobayashi, T., Yonekura, H., Ogata, H., Homma, T. J. Natl. Cancer Inst. (1987) [Pubmed]
  9. Discussion of case-control studies of Peleg, Stähelin, and Willett. Seigel, D. J. Natl. Cancer Inst. (1984) [Pubmed]
  10. Parenteral nutrition before surgery for gastrointestinal neoplasms. Koretz, R.L. Lancet (1983) [Pubmed]
  11. LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Abe, T., Unno, M., Onogawa, T., Tokui, T., Kondo, T.N., Nakagomi, R., Adachi, H., Fujiwara, K., Okabe, M., Suzuki, T., Nunoki, K., Sato, E., Kakyo, M., Nishio, T., Sugita, J., Asano, N., Tanemoto, M., Seki, M., Date, F., Ono, K., Kondo, Y., Shiiba, K., Suzuki, M., Ohtani, H., Shimosegawa, T., Iinuma, K., Nagura, H., Ito, S., Matsuno, S. Gastroenterology (2001) [Pubmed]
  12. Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group. Lutz, M.P., Cutsem, E.V., Wagener, T., Van Laethem, J.L., Vanhoefer, U., Wils, J.A., Gamelin, E., Koehne, C.H., Arnaud, J.P., Mitry, E., Husseini, F., Reichardt, P., El-Serafi, M., Etienne, P.L., Lingenfelser, T., Praet, M., Genicot, B., Debois, M., Nordlinger, B., Ducreux, M.P. J. Clin. Oncol. (2005) [Pubmed]
  13. Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952. Köhne, C.H., Wils, J., Lorenz, M., Schöffski, P., Voigtmann, R., Bokemeyer, C., Lutz, M., Kleeberg, C., Ridwelski, K., Souchon, R., El-Serafi, M., Weiss, U., Burkhard, O., Rückle, H., Lichnitser, M., Langenbuch, T., Scheithauer, W., Baron, B., Couvreur, M.L., Schmoll, H.J. J. Clin. Oncol. (2003) [Pubmed]
  14. Somatic mutation of the beta2-microglobulin gene associates with unfavorable prognosis in gastrointestinal cancer of the microsatellite mutator phenotype. Yamamoto, H., Yamashita, K., Perucho, M. Gastroenterology (2001) [Pubmed]
  15. ZBP-89-induced apoptosis is p53-independent and requires JNK. Bai, L., Yoon, S.O., King, P.D., Merchant, J.L. Cell Death Differ. (2004) [Pubmed]
  16. Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells. Akhtar, M., Cheng, Y., Magno, R.M., Ashktorab, H., Smoot, D.T., Meltzer, S.J., Wilson, K.T. Cancer Res. (2001) [Pubmed]
  17. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers. Nagata, Y., Abe, M., Kobayashi, K., Yoshida, K., Ishibashi, T., Naoe, T., Nakayama, E., Shiku, H. Cancer Res. (1990) [Pubmed]
  18. Development of cell cycle active drugs for the treatment of gastrointestinal cancers: a new approach to cancer therapy. Schwartz, G.K. J. Clin. Oncol. (2005) [Pubmed]
  19. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization. Zhou, W., Povoski, S.P., Longnecker, D.S., Bell, R.H. Cancer Res. (1992) [Pubmed]
  20. Potentiation of tumor lysis by a bispecific antibody that binds to CA19-9 antigen and the Fc gamma receptor expressed by human large granular lymphocytes. de Palazzo, I.G., Gercel-Taylor, C., Kitson, J., Weiner, L.M. Cancer Res. (1990) [Pubmed]
  21. Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome. Marsh, D.J., Roth, S., Lunetta, K.L., Hemminki, A., Dahia, P.L., Sistonen, P., Zheng, Z., Caron, S., van Orsouw, N.J., Bodmer, W.F., Cottrell, S.E., Dunlop, M.G., Eccles, D., Hodgson, S.V., Järvinen, H., Kellokumpu, I., Markie, D., Neale, K., Phillips, R., Rozen, P., Syngal, S., Vijg, J., Tomlinson, I.P., Aaltonen, L.A., Eng, C. Cancer Res. (1997) [Pubmed]
  22. Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves. Nishiyama, M., Yamamoto, W., Park, J.S., Okamoto, R., Hanaoka, H., Takano, H., Saito, N., Matsukawa, M., Shirasaka, T., Kurihara, M. Clin. Cancer Res. (1999) [Pubmed]
  23. MSH2 c.1452-1455delAATG is a founder mutation and an important cause of hereditary nonpolyposis colorectal cancer in the southern Chinese population. Chan, T.L., Chan, Y.W., Ho, J.W., Chan, C., Chan, A.S., Chan, E., Lam, P.W., Tse, C.W., Lee, K.C., Lau, C.W., Gwi, E., Leung, S.Y., Yuen, S.T. Am. J. Hum. Genet. (2004) [Pubmed]
  24. Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice. Nikitin, A.Y., Liu, C.Y., Flesken-Nikitin, A., Chen, C.F., Chen, P.L., Lee, W.H. Cancer Res. (2002) [Pubmed]
  25. HSF1 down-regulates XAF1 through transcriptional regulation. Wang, J., He, H., Yu, L., Xia, H.H., Lin, M.C., Gu, Q., Li, M., Zou, B., An, X., Jiang, B., Kung, H.F., Wong, B.C. J. Biol. Chem. (2006) [Pubmed]
  26. Inactivation of ELF/TGF-beta signaling in human gastrointestinal cancer. Katuri, V., Tang, Y., Marshall, B., Rashid, A., Jogunoori, W., Volpe, E.A., Sidawy, A.N., Evans, S., Blay, J., Gallicano, G.I., Premkumar Reddy, E., Mishra, L., Mishra, B. Oncogene (2005) [Pubmed]
  27. The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea. Kim, H.C., Wheeler, J.M., Kim, J.C., Ilyas, M., Beck, N.E., Kim, B.S., Park, K.C., Bodmer, W.F. Gut (2000) [Pubmed]
  28. Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action. Saleem, A., Yap, J., Osman, S., Brady, F., Suttle, B., Lucas, S.V., Jones, T., Price, P.M., Aboagye, E.O. Lancet (2000) [Pubmed]
  29. Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial. Bozzetti, F., Braga, M., Gianotti, L., Gavazzi, C., Mariani, L. Lancet (2001) [Pubmed]
  30. Liposomally entrapped second antibody improves tumour imaging with radiolabelled (first) antitumour antibody. Begent, R.H., Keep, P.A., Green, A.J., Searle, F., Bagshawe, K.D., Jewkes, R.F., Jones, B.E., Barratt, G.M., Ryman, B.E. Lancet (1982) [Pubmed]
  31. Radioimmunodetection of gastrointestinal neoplasms with antibodies to carcinoembryonic antigen. Hine, K.R., Bradwell, A.R., Reeder, T.A., Drolc, Z., Dykes, P.W. Cancer Res. (1980) [Pubmed]
  32. Molecular cloning of a human transmembrane-type protein tyrosine phosphatase and its expression in gastrointestinal cancers. Matozaki, T., Suzuki, T., Uchida, T., Inazawa, J., Ariyama, T., Matsuda, K., Horita, K., Noguchi, H., Mizuno, H., Sakamoto, C. J. Biol. Chem. (1994) [Pubmed]
WikiGenes - Universities